Tonix Pharmaceuticals is a specialty pharmaceutical company developing prescription medications for challenging disorders of the central nervous system. Seeking to address a significant unmet medical need, inadequate existing treatment options, and high dissatisfaction among patients and physicians, the company applies its core technology toward treating people suffering from central pain disorders by targeting their inability to obtain restorative sleep. The company’s lead pharmaceutical candidate for central pain is TNX-102 SL. For more information, visit the company’s website at www.tonixpharma.com.